Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids

References

• Adamsson Eryd, S., G. Östling, M. Rosvall, M. Persson, J. G. Smith, O. Melander, B. Hedblad, and G. Engström. 2014. Carotid intima-media thickness is associated with incidence of hospitalized atrial fibrillation. Atherosclerosis 233:673–678.
   PubMed Web of Science ®Google Scholar
• Albert, C. M., H. Campos, M. J. Stampfer, P. M. Ridker, J. E. Manson, W. C. Willett, and M. Jing. 2002. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. The New England Journal of Medicine 346:1113–1118.
   PubMed Web of Science ®Google Scholar
• Albert, C. M., C. H. Hennekens, C. J. O'Donnell, U. A. Ajani, V. J. Carey, W. C. Willett, J. N. Ruskin, and J. E. Manson. 1998. Fish consumption and risk of sudden cardiac death. Journal of the American Medical Association 279:23–28.
   PubMed Web of Science ®Google Scholar
• Aleksova, A., S. Masson, A. P. Maggioni, D. Lucci, G. Fabbri, L. Beretta, L. Mos, A. M. Paino, G. L. Nicolosi, R. Marchioli, et al. 2013. n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial. European Journal of Heart Failure 15:1289–1295.
   PubMed Web of Science ®Google Scholar
• Benjamin, E. J., D. Levy, S. M. Vaziri, R. B. D'Agostino, A. J. Belanger, and P. A. Wolf. 1994. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844.
   PubMed Web of Science ®Google Scholar
• Berry, J. D., R. J. Prineas, Lan. Horn, R. Passman, J. Larson, J. Goldberger, L. Snetselaar, L. Tinker, K. Liu, and D. M. Lloyd-Jones. 2010. Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative). American Journal of Cardiology 105:844–848.
   PubMed Web of Science ®Google Scholar
• Bianconi, L., L. Calò, M. Mennuni, L. Santini, P. Morosetti, P. Azzolini, G. Barbato, F. Biscione, P. Romano, and M. Santini. 2011. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study. Europace 13:174–181.
   PubMed Web of Science ®Google Scholar
• Billman, G. E. 2006. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. Pharmacology & Therapeutics 111:808–835.
   PubMed Web of Science ®Google Scholar
• Bjorgvinsdottir, L., D. O. Arnar, O. S. Indridason, R. Heidarsdottir, K. Skogstrand, B. Torfason, D. M. Hougaard, R. Palsson, and G. V. Skuladottir. 2013. Do high levels of n-3 polyunsaturated fatty acids in cell membranes increase the risk of postoperative atrial fibrillation? Cardiology 126:107–114.
   PubMed Web of Science ®Google Scholar
• Brouwer, I. A., J. Heeringa, J. M. Geleijnse, P. L. Zock, and J. C. M. Witteman. 2006. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. American Heart Journal 151:857–862.
   PubMed Web of Science ®Google Scholar
• Calò, L., L. Bianconi, F. Colivicchi, F. Lamberti, M. L. Loricchio, Ede. Ruvo, A. Meo, C. Pandozi, M. Staibano, and M. Santini. 2005. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. Journal of the American College of Cardiology 45:1723–1728.
   PubMed Web of Science ®Google Scholar
• Chiuve, S. E., R. K. Sandhu, M. V. Moorthy, R. J. Glynn, and C. M. Albert. 2015. Dietary Fat Intake Is Differentially Associated with Risk of Paroxysmal Compared with Sustained Atrial Fibrillation in Women. The Journal of Nutrition 145:2092–2101.
   PubMed Web of Science ®Google Scholar
• Colussi, G., C. Catena, S. Baroselli, E. Nadalini, R. Lapenna, A. Chiuch, and L. A. Sechi. 2007. Omega-3 fatty acids: from biochemistry to their clinical use in the prevention of cardiovascular disease. Recent Patents Cardiovasc. Drug Discov. 2:13–21.
   PubMedGoogle Scholar
• Colussi, G., C. Catena, V. Dialti, L. Mos, and L. A. Sechi. 2015a. The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients. Journal of Hypertension 33:993–1000.
   PubMed Web of Science ®Google Scholar
• Colussi, G., C. Catena, L. Mos, and L. A. Sechi. 2015b. The metabolic syndrome and the membrane content of polyunsaturated fatty acids in hypertensive patients. Metabolic Syndrome and Related Disorders 13:343–351.
   PubMed Web of Science ®Google Scholar
• Colussi, G., C. Catena, M. Novello, N. Bertin, and L. A. Sechi. 2017. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes. Nutrition, Metabolism & Cardiovascular Diseases 27:191–200.
   PubMed Web of Science ®Google Scholar
• Colussi, G., C. Catena, and L. A. Sechi. 2014. ω-3 Polyunsaturated fatty acids effects on the cardiometabolic syndrome and their role in cardiovascular disease prevention: An update from the recent literature. Recent Advances in Cardiovascular Drug Discovery 9:78–96.
   PubMedGoogle Scholar
• Colussi, G. L., S. Baroselli, and L. Sechi. 2004. Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects. Clinical Nutrition 23:1246–1247.
   PubMed Web of Science ®Google Scholar
• Conen, D., U. B. Tedrow, B. A. Koplan, R. J. Glynn, J. E. Buring, and C. M. Albert. 2009. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 119:2146–2152.
   PubMed Web of Science ®Google Scholar
• Costanzo, S., Vdi. Niro, D. Castelnuovo, G. A., D. F., G. M.B., G. de, and L. Iacoviello. 2013. Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis. The Journal of Thoracic and Cardiovascular Surgery 146:906–911.
   PubMed Web of Science ®Google Scholar
• da Cunha, D. N. Q., R. L. Hamlin, G. E. Billman, and C. A. Carnes. 2007. n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. British Journal of Pharmacology 150:281–285.
   PubMed Web of Science ®Google Scholar
• Darghosian, L., M. Free, J. Li, T. Gebretsadik, A. Bian, A. Shintani, B. F. McBride, J. Solus, G. Milne, G. H. Crossley, et al. 2015. Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation. American Journal of Cardiology 115:196–201.
   PubMed Web of Science ®Google Scholar
• Dublin, S., B. French, N. L. Glazer, K. L. Wiggins, T. Lumley, B. M. Psaty, N. L. Smith, and S. R. Heckbert. 2006. Risk of new-onset atrial fibrillation in relation to body mass index. Archives of Internal Medicine 166:2322–2328.
   PubMedGoogle Scholar
• Farquharson, A. L., R. G. Metcalf, P. Sanders, R. Stuklis, J. R. M. Edwards, R. A. Gibson, L. G. Cleland, T. R. Sullivan, M. J. James, and G. D. Young. 2011. Effect of dietary fish oil on atrial fibrillation after cardiac surgery. American Journal of Cardiology 108:851–856.
   PubMed Web of Science ®Google Scholar
• Frost, L., and P. Vestergaard. 2005. n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. The American Journal of Clinical Nutrition 81:50–54.
   PubMed Web of Science ®Google Scholar
• Gage, B. F., A. D. Waterman, W. Shannon, M. Boechler, M. W. Rich, and M. J. Radford. 2001. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870.
   PubMed Web of Science ®Google Scholar
• Gami, A. S., G. Pressman, S. M. Caples, R. Kanagala, J. J. Gard, D. E. Davison, J. F. Malouf, N. M. Ammash, P. A. Friedman, and V. K. Somers. 2004. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110:364–367.
   PubMed Web of Science ®Google Scholar
• Garg, M. L., J. Leitch, R. J. Blake, and R. Garg. 2006. Long-chain n-3 polyunsaturated fatty acid incorporation into human atrium following fish oil supplementation. Lipids 41:1127–1132.
   PubMed Web of Science ®Google Scholar
• GISSI-Prevenzione Investigators. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354:447–455.
   PubMed Web of Science ®Google Scholar
• Gronroos, N. N., A. M. Chamberlain, A. R. Folsom, E. Z. Soliman, S. K. Agarwal, J. A. Nettleton, and A. Alonso. 2012. Fish, fish-derived n-3 fatty acids, and risk of incident atrial fibrillation in the Atherosclerosis Risk in Communities (ARIC) study. PloS One 7:e36686.
   PubMed Web of Science ®Google Scholar
• Grundvold, I., P. T. Skretteberg, K. Liestøl, G. Erikssen, S. E. Kjeldsen, H. Arnesen, J. Erikssen, and J. Bodegard. 2012. Upper Normal Blood Pressures Predict Incident Atrial Fibrillation in Healthy Middle-Aged Men A 35-Year Follow-Up Study. Hypertension 59:198–204.
   PubMed Web of Science ®Google Scholar
• Hansen, T. W., L. Thijs, Y. Li, J. Boggia, M. Kikuya, K. Björklund-Bodegård, T. Richart, T. Ohkubo, J. Jeppesen, C. Torp-Pedersen, et al. 2010. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 55:1049–1057.
   PubMed Web of Science ®Google Scholar
• Heidarsdottir, R., D. O. Arnar, G. V. Skuladottir, B. Torfason, V. Edvardsson, G. Gottskalksson, R. Palsson, and O. S. Indridason. 2010. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 12:356–363.
   PubMed Web of Science ®Google Scholar
• Heidt, M. C., M. Vician, S. K. H. Stracke, T. Stadlbauer, M. T. Grebe, A. Boening, P. R. Vogt, and A. Erdogan. 2009. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thoracic and Cardiovascular Surgery 57:276–280.
   PubMed Web of Science ®Google Scholar
• Honen, B. N., and D. A. Saint. 2002a. Polyunsaturated dietary fats change the properties of calcium sparks in adult rat atrial myocytes. The Journal of Nutritional Biochemistry 13:322–329.
   PubMed Web of Science ®Google Scholar
• Honen, B. N., and D. A. Saint. 2002b. Polyunsaturated dietary fats change the properties of calcium sparks in adult rat atrial myocytes. The Journal of Nutritional Biochemistry 13:322–329.
   PubMed Web of Science ®Google Scholar
• Horio, T., Y. Iwashima, K. Kamide, T. Tokudome, F. Yoshihara, S. Nakamura, and Y. Kawano. 2010. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. Journal of Hypertension 28:1738–1744.
   PubMed Web of Science ®Google Scholar
• Hurley, V., R. Ireson, K. Fletcher, G. Y. H. Lip, F. D. R. Hobbs, J. Mant, and B. A. F. T.A. Investigators. 2007. A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial. International Journal of Cardiology 117:152–156.
   PubMed Web of Science ®Google Scholar
• Jahangiri, A., W. R. Leifert, G. S. Patten, and E. J. McMurchie. 2000. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Molecular and Cellular Biochemistry. 206:33–41.
   PubMed Web of Science ®Google Scholar
• Kannel, W. B., P. A. Wolf, E. J. Benjamin, and D. Levy. 1998. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. American Journal of Cardiology 82:2N–9N.
   PubMed Web of Science ®Google Scholar
• Kowey, P. R., J. A. Reiffel, K. A. Ellenbogen, G. V. Naccarelli, and C. M. Pratt. 2010. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA 304:2363–2372.
   PubMed Web of Science ®Google Scholar
• Krahn, A. D., J. Manfreda, R. B. Tate, F. A. Mathewson, and T. E. Cuddy. 1995. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. American Journal of Medicine 98:476–484.
   PubMed Web of Science ®Google Scholar
• Kromhout, D., J. M. Geleijnse, J. de Goede, L. M. Oude Griep, B. J. M. Mulder, M.-J. de Boer, J. W. Deckers, E. Boersma, P. L. Giltay, and E. J. Zock. 2011. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. Diabetes Care 34:2515–2520.
   PubMed Web of Science ®Google Scholar
• Kumar, S., F. Sutherland, J. M. S. Lee, T. Robinson, P. M. Heck, M. C. G. Wong, N. F. Kelland, M. L. Garg, and P. B. Sparks. 2013. Effects of high dose intravenous fish oil on human atrial electrophysiology: Implications for possible anti- and pro-arrhythmic mechanisms in atrial fibrillation. International Journal of Cardiology 168:2754–2760.
   PubMed Web of Science ®Google Scholar
• Kumar, S., F. Sutherland, J. B. Morton, G. Lee, J. Morgan, J. Wong, D. E. Eccleston, J. Voukelatos, M. L. Garg, and P. B. Sparks. 2012. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm 9:483–491.
   PubMed Web of Science ®Google Scholar
• Larsson, S. C., and A. Wolk. 2017. Fish, long-chain omega-3 polyunsaturated fatty acid intake and incidence of atrial fibrillation: A pooled analysis of two prospective studies. Clinical Nutrition 36:537–541.
   PubMed Web of Science ®Google Scholar
• Larstorp, A. C. K., I. Ariansen, K. Gjesdal, M. H. Olsen, H. Ibsen, R. B. Devereux, P. M. Okin, B. Dahlöf, S. E. Kjeldsen, and K. Wachtell. 2012. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study. Hypertension 60:347–353.
   PubMed Web of Science ®Google Scholar
• Lau, D. H., L. T. Huynh, D. P. Chew, C. M. Astley, A. Soman, and P. Sanders. 2009. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. American Journal of Cardiology 104:1317–1323.
   PubMed Web of Science ®Google Scholar
• Lau, D. H., M. E. Middeldorp, A. G. Brooks, A. N. Ganesan, K. C. Roberts-Thomson, M. K. Stiles, D. P. Leong, H. S. Abed, H. S. Lim, C. X. Wong, et al. 2013. Aortic stiffness in lone atrial fibrillation: a novel risk factor for arrhythmia recurrence. PloS One 8:e76776.
   PubMed Web of Science ®Google Scholar
• Lip, G. Y. H., L. Frison, M. Grind, and S. P. O. R. T. I. F. Invetigators. 2007. Effect of hypertension on anticoagulated patients with atrial fibrillation. European Heart Journal 28:752–759.
   PubMed Web of Science ®Google Scholar
• Lip, G. Y. H., R. Nieuwlaat, R. Pisters, D. A. Lane, and H. J. G. M. Crijns. 2010. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272.
   PubMed Web of Science ®Google Scholar
• Macchia, A., H. Grancelli, S. Varini, D. Nul, N. Laffaye, J. Mariani, D. Ferrante, R. Badra, J. Figal, S. Ramos, et al. 2013. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. Journal of the American College of Cardiology 61:463–468.
   PubMed Web of Science ®Google Scholar
• Marchioli, R., F. Barzi, E. Bomba, C. Chieffo, D. Di Gregorio, R. Di Mascio, M. G. Franzosi, E. Geraci, G. Levantesi, A. P. Maggioni, et al. 2002. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897–1903.
   PubMed Web of Science ®Google Scholar
• Mariani, J., H. C. Doval, D. Nul, S. Varini, H. Grancelli, D. Ferrante, G. Tognoni, and A. Macchia. 2013. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association 2:e005033.
   PubMed Web of Science ®Google Scholar
• Matthan, N. R., H. Jordan, M. Chung, A. H. Lichtenstein, D. A. Lathrop, and J. Lau. 2005. A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism 54:1557–1565.
   PubMed Web of Science ®Google Scholar
• McLennan, P. L. 2014. Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids. European Journal of Applied Physiology 114:1333–1356.
   PubMed Web of Science ®Google Scholar
• Metcalf, R. G., M. J. James, R. A. Gibson, J. R. Edwards, J. Stubberfield, R. Stuklis, K. Roberts-Thomson, G. D. Young, and L. G. Cleland. 2007. Effects of fish-oil supplementation on myocardial fatty acids in humans. The American Journal of Clinical Nutrition 85:1222–1228.
   PubMed Web of Science ®Google Scholar
• Metcalf, R. G., G. V. Skuladottir, O. S. Indridason, T. R. Sullivan, L. Bjorgvinsdottir, P. Sanders, D. O. Arnar, R. A. Gibson, R. Heidarsdottir, L. G. Cleland, et al. 2014. U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgery. European Journal of Clinical Nutrition 68:114–118.
   PubMed Web of Science ®Google Scholar
• Mitchell, G. F., H. Parise, E. J. Benjamin, M. G. Larson, M. J. Keyes, J. A. Vita, R. S. Vasan, and D. Levy. 2004. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 43:1239–1245.
   PubMed Web of Science ®Google Scholar
• Mitchell, G. F., R. S. Vasan, M. J. Keyes, H. Parise, T. J. Wang, M. G. Larson, R. B. D'Agostino, W. B. Kannel, D. Levy, and E. J. Benjamin. 2007. Pulse pressure and risk of new-onset atrial fibrillation. JAMA 297:709–715.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., R. Marchioli, A. Macchia, M. G. Silletta, P. Ferrazzi, T. J. Gardner, R. Latini, P. Libby, F. Lombardi, P. T. O'Gara, et al. 2012. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA 308:2001–2011.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., B. M. Psaty, E. B. Rimm, R. N. Lemaitre, G. L. Burke, M. F. Lyles, D. Lefkowitz, and D. S. Siscovick. 2004. Fish intake and risk of incident atrial fibrillation. Circulation 110:368–373.
   PubMed Web of Science ®Google Scholar
• Naccarelli, G. V., H. Varker, J. Lin, and K. L. Schulman. 2009. Increasing prevalence of atrial fibrillation and flutter in the United States. American Journal of Cardiology 104:1534–1539.
   PubMed Web of Science ®Google Scholar
• Nigam, A., M. Talajic, D. Roy, S. Nattel, J. Lambert, A. Nozza, P. Jones, V. R. Ramprasath, G. O'Hara, S. Kopecky, et al. 2014. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. Journal of the American College of Cardiology 64:1441–1448.
   PubMed Web of Science ®Google Scholar
• Ninio, D. M., K. J. Murphy, P. R. Howe, and D. A. Saint. 2005. Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model. Journal of Cardiovascular Electrophysiology 16:1189–1194.
   PubMed Web of Science ®Google Scholar
• Nodari, S., M. Triggiani, U. Campia, A. Manerba, G. Milesi, B. M. Cesana, M. Gheorghiade, and L. Dei Cas. 2011. n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 124:1100–1106.
   PubMed Web of Science ®Google Scholar
• Oldgren, J., J. S. Healey, M. Ezekowitz, P. Commerford, A. Avezum, P. Pais, J. Zhu, P. Jansky, A. Sigamani, C. A. Morillo, et al. 2014. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation 129:1568–1576.
   PubMed Web of Science ®Google Scholar
• Paquette, M., D. Roy, M. Talajic, D. Newman, A. Couturier, C. Yang, and P. Dorian. 2000. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. The American Journal of Cardiology 86:764–768.
   PubMed Web of Science ®Google Scholar
• Rix, T. A., A. M. Joensen, S. Riahi, S. Lundbye-Christensen, K. Overvad, and E. B. Schmidt. 2013. Marine n-3 fatty acids in adipose tissue and development of atrial fibrillation: A Danish cohort study. Heart 99:1519–1524.
   PubMed Web of Science ®Google Scholar
• Rix, T. A., A. M. Joensen, S. Riahi, S. Lundbye-Christensen, A. Tjønneland, E. B. Schmidt, and K. Overvad. 2014. A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study. Europace 16:1554–1561.
   PubMed Web of Science ®Google Scholar
• Rizos, I., A. G. Rigopoulos, A. S. Kalogeropoulos, S. Tsiodras, S. Dragomanovits, E. A. Sakadakis, E. Faviou, and D. T. Kremastinos. 2010. Hypertension and paroxysmal atrial fibrillation:a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence. Journal of Human Hypertension 24:447–457.
   PubMed Web of Science ®Google Scholar
• Roetker, N. S., L. Y. Chen, S. R. Heckbert, S. Nazarian, E. Z. Soliman, D. A. Bluemke, J. A. C. Lima, and A. Alonso. 2014. Relation of systolic, diastolic, and pulse pressures and aortic distensibility with atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis). American Journal of Cardiology 114:587–592.
   PubMed Web of Science ®Google Scholar
• Rothwell, P. M., S. C. Howard, E. Dolan, E. O'Brien, J. E. Dobson, B. Dahlöf, P. S. Sever, and N. R. Poulter. 2010. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375:895–905.
   PubMed Web of Science ®Google Scholar
• Sandesara, C. M., M. K. Chung, D. R. Van Wagoner, T. A. Barringer, K. Allen, H. M. Ismail, B. Zimmerman, and B. Olshansky. 2012. A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery: The FISH Trial. Journal of the American Heart Association 1:e000547.
   PubMed Web of Science ®Google Scholar
• Saravanan, P., B. Bridgewater, A. L. West, S. C. O'Neill, P. C. Calder, and N. C. Davidson. 2010. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial. Circulation: Arrhythmia and Electrophysiology 3:46–53.
   PubMed Web of Science ®Google Scholar
• Schotten, U., S. Verheule, P. Kirchhof, and A. Goette. 2011. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiological Reviews 91:265–325.
   PubMed Web of Science ®Google Scholar
• Shen, J., V. M. Johnson, L. M. Sullivan, P. F. Jacques, J. W. Magnani, S. A. Lubitz, S. Pandey, D. Levy, R. S. Vasan, P. A. Quatromoni, et al. 2011. Dietary factors and incident atrial fibrillation: the Framingham Heart Study. The American Journal of Clinical Nutrition 93:261–266.
   PubMed Web of Science ®Google Scholar
• Siscovick, D. S., T. A. Barringer, A. M. Fretts, J. H. Y. Wu, A. H. Lichtenstein, R. B. Costello, P. M. Kris-Etherton, T. A. Jacobson, M. B. Engler, H. M. Alger, et al. 2017. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation 135:e867–e884.
   PubMed Web of Science ®Google Scholar
• Siscovick, D. S., T. E. Raghunathan, I. King, S. Weinmann, K. G. Wicklund, J. Albright, V. Bovbjerg, P. Arbogast, H. Smith, and L. H. Kushi. 1995. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274:1363–1367.
   PubMed Web of Science ®Google Scholar
• Skuladottir, G. V., R. Heidarsdottir, D. O. Arnar, B. Torfason, V. Edvardsson, G. Gottskalksson, R. Palsson, and O. S. Indridason. 2011. Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery. European Journal of Clinical Investigation 41:995–1003.
   PubMed Web of Science ®Google Scholar
• Sorice, M., F. P. Tritto, C. Sordelli, R. Gregorio, and L. Piazza. 2011. N-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing “on-pump” coronary artery bypass graft surgery. Monaldi Archives for Chest Disease 76:93–98.
   PubMedGoogle Scholar
• Tanner, R. M., U. Baber, A. P. Carson, J. Voeks, T. M. Brown, E. Z. Soliman, V. J. Howard, and P. Muntner. 2011. Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). American Journal of Cardiology 108:227–232.
   PubMed Web of Science ®Google Scholar
• Thomas, M. C., S. Dublin, R. C. Kaplan, N. L. Glazer, T. Lumley, W. T. Longstreth, N. L. Smith, B. M. Psaty, D. S. Siscovick, and S. R. Heckbert. 2008. Blood pressure control and risk of incident atrial fibrillation. American Journal of Hypertension 21:1111–1116.
   PubMed Web of Science ®Google Scholar
• Tsang, T. S. M., B. J. Gersh, C. P. Appleton, A. J. Tajik, M. E. Barnes, K. R. Bailey, J. K. Oh, C. Leibson, S. C. Montgomery, and J. B. Seward. 2002. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. Journal of the American College of Cardiology 40:1636–1644.
   PubMed Web of Science ®Google Scholar
• Vagaonescu, T. D., A. C. Wilson, and J. B. Kostis. 2008. Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study. Hypertension 51:1552–1556.
   PubMed Web of Science ®Google Scholar
• Valbusa, F., S. Bonapace, L. Bertolini, L. Zenari, G. Arcaro, and G. Targher. 2012. Increased pulse pressure independently predicts incident atrial fibrillation in patients with type 2 diabetes. Diabetes Care 35:2337–2339.
   PubMed Web of Science ®Google Scholar
• Verdecchia, P., G. Dagenais, J. Healey, P. Gao, A. L. Dans, I. Chazova, A. S. Binbrek, G. Iacobellis, R. Ferreira, N. Holwerda, et al. 2012. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies. Journal of Hypertension 30:1004–1014.
   PubMed Web of Science ®Google Scholar
• Verdecchia, P., G. Reboldi, R. Gattobigio, M. Bentivoglio, C. Borgioni, F. Angeli, E. Carluccio, M. G. Sardone, and C. Porcellati. 2003. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 41:218–223.
   PubMed Web of Science ®Google Scholar
• Virtanen, J. K., J. Mursu, S. Voutilainen, and T.-P. Tuomainen. 2009. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 120:2315–2321.
   PubMed Web of Science ®Google Scholar
• Vyssoulis, G., E. Karpanou, D. Adamopoulos, S.-M. Kyvelou, V. Tzamou, A. Michaelidis, and C. Stefanadis. 2013. Metabolic syndrome and atrial fibrillation in patients with essential hypertension. Nutrition, Metabolism & Cardiovascular Diseases 23:109–114.
   PubMed Web of Science ®Google Scholar
• Webb, A. J. S., and P. M. Rothwell. 2010. Blood pressure variability and risk of new-onset atrial fibrillation: a systematic review of randomized trials of antihypertensive drugs. Stroke 41:2091–2093.
   PubMed Web of Science ®Google Scholar
• Webb, A. J. S., and P. M. Rothwell. 2014. Physiological correlates of beat-to-beat, ambulatory, and day-to-day home blood pressure variability after transient ischemic attack or minor stroke. Stroke 45:533–538.
   PubMed Web of Science ®Google Scholar
• Wilke, T., A. Groth, S. Mueller, M. Pfannkuche, F. Verheyen, R. Linder, U. Maywald, R. Bauersachs, and G. Breithardt. 2013. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace 15:486–493.
   PubMed Web of Science ®Google Scholar
• Wu, J. H. Y., R. N. Lemaitre, I. B. King, X. Song, F. M. Sacks, E. B. Rimm, S. R. Heckbert, D. S. Siscovick, and D. Mozaffarian. 2012. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation 125:1084–1093.
   PubMed Web of Science ®Google Scholar
• Zhang, B., Y. Zhen, A. Tao, Z. Bao, and G. Zhang. 2014. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials. Journal of Cardiology 63:53–59.
   PubMed Web of Science ®Google Scholar